Characteristics of HIV antiretroviral treatments, access and adherence in an ethnically
diverse sample of men who have sex with men.
Halkitis PN, Parsons JT, Wolitski RJ, Remien RH., et al
AIDS Care 2003 Feb;15(1):89-102
Abstract

Availability of combination therapy for HIV: effects on sexual risk taking in a sample of
high-risk gay and bisexual men.
Dilley JW, Woods WJ, Sabatino J, et al.
AIDS Care 2003 Feb;15(1):27-37
Abstract

Protease inhibitor combination therapy and decreased condom use among gay men.
DiClemente RJ, Funkhouser E, Wingood G, et al,
South Med J 2002 Apr;95(4):421-5
Abstract

Impact of highly active antiretroviral treatment on HIV seroincidence among men
who have sex with men:
San Francisco. Katz MH, Schwarcz SK, Kellogg TA, et al.
Am J Public Health 2002 Mar;92(3):388-94
Abstract

Effect of highly active antiretroviral therapy on the natural history of anal squamous
intraepithelial lesions and anal human papillomavirus infection.
Palefsky JM, Holly EA, Ralston ML
J Acquir Immune Defic Syndr 2001 Dec 15;28(5):422-8
Abstract

Association of antiretroviral therapy with detection of HIV-1 RNA and DNA in the
anorectal mucosa of homosexual men.
Lampinen TM, Critchlow CW, Kuypers JM, et al
AIDS 2000 Mar 31;14(5):F69-75
Abstract

Adherence to HIV Medications in a Cohort of Men Who Have Sex With Men: Impact of
September 11th.
Halkitis PN, Kutnick AH, Rosof E, et al.
J Urban Health 2003 Mar;80(1):161-6
Abstract
 

Correlates of resistance to HIV-1 infection in homosexual men with high-risk sexual
behaviour.
Koning FA, Jansen CA, Dekker J, et al 
AIDS. 2004 May 21;18(8):1117-1126.
Abstract

Drug resistance prevalence declines in recently infected subjects having sex with men
but not in those using drug injections: results from the Montreal Primary HIV-Infection
Cohort
JP Routy, B Brenner, D Rouleau, et al.
(12 Int Drug Resistance Workshop)
Abstract